Regional Health is involved in small bowel cancer research trials. Below is more information about the purpose and who the physician (principal investigator) is for each trial. For more in-depth information on the research studies, click the blue name which will lead you to the U.S. National Institute of Health website or call (605) 755-2300.
A multicenter phase II study of pembrolizumab (MK-3475) in patients with advanced small bowel adenocarcinomas
|To learn more, contact:
John T. Vucurevich Cancer Care Institute
Michael Robinson, MD